Literature DB >> 27662013

Increased risk of axial fractures in patients with untreated chronic lymphocytic leukemia: a population-based analysis.

Adam J Olszewski1,2, Roee Gutman3, Charles B Eaton4,5.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27662013      PMCID： PMC5479616          DOI： 10.3324/haematol.2016.148858

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  Disease-specific complications of chronic lymphocytic leukemia.

Authors:  Claire Dearden
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

3.  Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Matthew T Drake; Matthew J Maurer; Cristine Allmer; Kari G Rabe; Susan L Slager; George J Weiner; Timothy G Call; Brian K Link; Clive S Zent; Neil E Kay; Curtis A Hanson; Thomas E Witzig; James R Cerhan
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

4.  Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.

Authors:  Adam J Olszewski; Hammad Shafqat; Shihab Ali
Journal:  Leuk Lymphoma       Date:  2014-08-18

5.  Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma.

Authors:  C Marcelli; D Chappard; J F Rossi; J Jaubert; C Alexandre; P Dessauw; P Baldet; R Bataille
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

Review 6.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

7.  Clinical and demographic factors associated with fractures among older Americans.

Authors:  A J Taylor; L C Gary; T Arora; D J Becker; J R Curtis; M L Kilgore; M A Morrisey; K G Saag; R Matthews; H Yun; W Smith; E Delzell
Journal:  Osteoporos Int       Date:  2010-06-18       Impact factor: 4.507

8.  Effect of chlorambucil on bone mineral density in the course of chronic lymphoid leukemia.

Authors:  J Leone; J P Vilque; D Jolly; B Pignon; A M Blaise; J L Pennaforte; J P Eschard; J C Etienne
Journal:  Eur J Haematol       Date:  1998-08       Impact factor: 2.997

9.  Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.

Authors:  Raymond Lai; Susan O'Brien; Taghi Maushouri; Anna Rogers; Hagop Kantarjian; Micheal Keating; Maher Albitar
Journal:  Cancer       Date:  2002-09-01       Impact factor: 6.860

10.  Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.

Authors:  Jan A Burger; Alessandra Tedeschi; Paul M Barr; Tadeusz Robak; Carolyn Owen; Paolo Ghia; Osnat Bairey; Peter Hillmen; Nancy L Bartlett; Jianyong Li; David Simpson; Sebastian Grosicki; Stephen Devereux; Helen McCarthy; Steven Coutre; Hang Quach; Gianluca Gaidano; Zvenyslava Maslyak; Don A Stevens; Ann Janssens; Fritz Offner; Jiří Mayer; Michael O'Dwyer; Andrzej Hellmann; Anna Schuh; Tanya Siddiqi; Aaron Polliack; Constantine S Tam; Deepali Suri; Mei Cheng; Fong Clow; Lori Styles; Danelle F James; Thomas J Kipps
Journal:  N Engl J Med       Date:  2015-12-06       Impact factor: 91.245
View more
  5 in total

1.  Use of bone-modifying agents and clinical outcomes in older adults with multiple myeloma.

Authors:  Adam J Olszewski; Peter M Barth; John L Reagan
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

2.  A case of bone lesion in a patient with relapsed chronic lymphocytic leukemia and review of the literature.

Authors:  Francesca Bacchiarri; Alessandro Gozzetti; Nicola Mondanelli; Stefano Lazzi; Monica Bocchia
Journal:  Clin Case Rep       Date:  2022-04-04

3.  Chronic Lymphocytic Leukemia: A Rare Cause of Pathological Fracture of the Femur.

Authors:  Parita Soni; Nidhi Aggarwal; Anand Rai; Vivek Kumar; Kamholz Stephan; Yoon Taek; Kupfer Yizhak
Journal:  J Investig Med High Impact Case Rep       Date:  2017-10-03

4.  Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines.

Authors:  Paolo Giannoni; Cecilia Marini; Giovanna Cutrona; Serena Matis; Maria Cristina Capra; Francesca Puglisi; Paola Luzzi; Simona Pigozzi; Gabriele Gaggero; Antonino Neri; Katia Todoerti; Fortunato Morabito; Adalberto Ibatici; Maurizio Miglino; Micaela Bergamaschi; Silvia Bruno; Gian Mario Sambuceti; Jean Louis Ravetti; Manlio Ferrarini; Franco Fais; Daniela de Totero
Journal:  Haematologica       Date:  2021-10-01       Impact factor: 9.941

5.  Multivariate transcriptome analysis identifies networks and key drivers of chronic lymphocytic leukemia relapse risk and patient survival.

Authors:  Ti'ara L Griffen; Eric B Dammer; Courtney D Dill; Kaylin M Carey; Corey D Young; Sha'Kayla K Nunez; Adaugo Q Ohandjo; Steven M Kornblau; James W Lillard
Journal:  BMC Med Genomics       Date:  2021-06-29       Impact factor: 3.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.